e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
COPD: systemic inflammation and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The Importance of the local expression of acute phase reactants in the COPD
B. Rojano, C. Calero, F. J. Saenz, M. López-Porras, E. Arellano, A. Blanco, J. L. Lopez-Campos (Seville, Spain)
Source:
Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Session:
COPD: systemic inflammation and comorbidities
Session type:
Thematic Poster Session
Number:
559
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Rojano, C. Calero, F. J. Saenz, M. López-Porras, E. Arellano, A. Blanco, J. L. Lopez-Campos (Seville, Spain). The Importance of the local expression of acute phase reactants in the COPD. Eur Respir J 2010; 36: Suppl. 54, 559
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Serum acute phase reactants in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002
The relations between levels of acute phase reactants and severity of community acquired pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 464s
Year: 2001
Relation between level of acute phase proteins and efficiency of treatment in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Can acute phase proteins predict survival in ventilated patients with acute exacerbation of COPD?
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
The dynamics of reactants of acute phase of inflammation in adolescents with newly detected drug-resistant TB during the treatment
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Acute phase markers in elderly patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Time course of systemic inflammatory markers during acute exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD.
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Changes in lung function in acute COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Prognostic impact of pleuropulmonary pathologies in the early phase of acute pancreatitis.
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Local and systemic inflammation in acute viral exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept